تمرینات تناوبی با شدت بالا همراه با مکمل زعفران، نشانگرهای استرس-التهابی را در زنان چاق مبتلا به دیابت نوع 2 تعدیل می‌کند.

[1] Rabinovitch A, Suarez-Pinzon WL. Cytokines and their roles in pancreatic islet β-cell destruction and insulin-dependent diabetes mellitus. Biochemical pharmacology. 1998;55(8):1139-49.

[2] Jiménez-Maldonado A, García-Suárez PC, Rentería I, Moncada-Jiménez J, Plaisance EP. Impact of high-intensity interval training and sprint interval training on peripheral markers of glycemic control in metabolic syndrome and type 2 diabetes. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 2020;1866(8):165820.

[3] Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes care. 2009;32(1):193-203.

[4] Pocock SJ, Wang D, Pfeffer MA, Yusuf S, McMurray JJ, Swedberg KB, et al. Predictors of mortality and morbidity in patients with chronic heart failure. European heart journal. 2006;27(1):65-75.

[5] Shah AD, Langenberg C, Rapsomaniki E, Denaxas S, Pujades-Rodriguez M, Gale CP, et al. Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1· 9 million people. The lancet Diabetes & endocrinology. 2015;3(2):105-13.

[6] McMurray JJ, Gerstein HC, Holman RR, Pfeffer MA. Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored. The lancet Diabetes & endocrinology. 2014;2(10):843-51.

[7] Ohkuma T, Jun M, Woodward M, Zoungas S, Cooper ME, Grobbee DE, et al. Cardiac stress and inflammatory markers as predictors of heart failure in patients with type 2 diabetes: the ADVANCE trial. Diabetes Care. 2017;40(9):1203-9.

[8] Association AD. 13. Children and adolescents: standards of medical care in diabetes—2021. Diabetes care. 2021;44(Supplement_1):S180-S99.

[9] Colberg SR, Sigal RJ, Yardley JE, Riddell MC, Dunstan DW, Dempsey PC, et al. Physical activity/exercise and diabetes: a position statement of the American Diabetes Association. Diabetes care. 2016;39(11):2065-79.

[10] Chang C, Khurana S, Strodel R, Camp A, Magenheimer E, Hawley N. Perceived barriers to physical activity among low-income Latina women at risk for type 2 diabetes. The Diabetes Educator. 2018;44(5):444-53.

[11] Thomas N, Alder E, Leese G. Barriers to physical activity in patients with diabetes. Postgraduate medical journal. 2004;80(943):287-91.

[12] Burgomaster KA, Howarth KR, Phillips SM, Rakobowchuk M, MacDonald MJ, McGee SL, et al. Similar metabolic adaptations during exercise after low volume sprint interval and traditional endurance training in humans. The Journal of physiology. 2008;586(1):151-60.

[13] Gibala MJ, Little JP, Van Essen M, Wilkin GP, Burgomaster KA, Safdar A, et al. Short‐term sprint interval versus traditional endurance training: similar initial adaptations in human skeletal muscle and exercise performance. The Journal of physiology. 2006;575(3):901-11.

[14] Heiskanen MA, Leskinen T, Heinonen IH, Löyttyniemi E, Eskelinen J-J, Virtanen K, et al. Right ventricular metabolic adaptations to high-intensity interval and moderate-intensity continuous training in healthy middle-aged men. American Journal of Physiology-Heart and Circulatory Physiology. 2016;311(3):H667-H75.

[15] MacInnis MJ, Gibala MJ. Physiological adaptations to interval training and the role of exercise intensity. The Journal of physiology. 2017;595(9):2915-30.

[16] Chavanelle V, Boisseau N, Otero YF, Combaret L, Dardevet D, Montaurier C, et al. Effects of high-intensity interval training and moderate-intensity continuous training on glycaemic control and skeletal muscle mitochondrial function in db/db mice. Scientific reports. 2017;7(1):1-10.

[17] Weaver CM. Bioactive foods and ingredients for health. Advances in Nutrition. 2014;5(3):306S-11S.

[18] Ghaffari S, Roshanravan N. Saffron; An updated review on biological properties with special focus on cardiovascular effects. Biomedicine & Pharmacotherapy. 2019;109:21-7.

[19] Ghaffari S, Roshanravan N. The role of nutraceuticals in prevention and treatment of hypertension: An updated review of the literature. Food Research International. 2020;128:108749.

[20] Jose Bagur M, Alonso Salinas GL, Jiménez-Monreal AM, Chaouqi S, Llorens S, Martínez-Tomé M, et al. Saffron: An old medicinal plant and a potential novel functional food. Molecules. 2017;23(1):30.

[21] Khatir SA, Bayatian A, Barzegari A, Roshanravan N, Safaiyan A, Pavon-Djavid G, et al. Saffron (Crocus sativus L.) supplements modulate circulating MicroRNA (miR-21) in atherosclerosis patients; a randomized, double-blind, placebo-controlled trial. Iranian Red Crescent Medical Journal. 2018;20(10).

[22] Cai J, Yi FF, Bian ZY, Shen DF, Yang L, Yan L, et al. Crocetin protects against cardiac hypertrophy by blocking MEK‐ERK1/2 signalling pathway. Journal of cellular and molecular medicine. 2009;13(5):909-25.

[23] Hazman Ö, Ovalı S. Investigation of the anti-inflammatory effects of safranal on high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model. Inflammation. 2015;38(3):1012-9.

[24] Azimi P, Ghiasvand R, Feizi A, Hariri M, Abbasi B. Effects of cinnamon, cardamom, saffron, and ginger consumption on markers of glycemic control, lipid profile, oxidative stress, and inflammation in type 2 diabetes patients. The review of diabetic studies: RDS. 2014;11(3):258.

[25] Christodoulou E, Kadoglou N, Stasinopoulou M, Konstandi O, Kenoutis C, Kakazanis Z, et al. Crocus sativus L. aqueous extract reduces atherogenesis, increases atherosclerotic plaque stability and improves glucose control in diabetic atherosclerotic animals. Atherosclerosis. 2018;268:207-14.

[26] Ebrahimi F, Sahebkar A, Aryaeian N, Pahlavani N, Fallah S, Moradi N, et al. Effects of saffron supplementation on inflammation and metabolic responses in type 2 diabetic patients: A randomized, double-blind, placebo-controlled trial. Diabetes, metabolic syndrome and obesity: targets and therapy. 2019;12:2107.

[27] Mobasseri M, Ostadrahimi A, Tajaddini A, Asghari S, Barati M, Akbarzadeh M, et al. Effects of saffron supplementation on glycemia and inflammation in patients with type 2 diabetes mellitus: a randomized double-blind, placebo-controlled clinical trial study. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2020;14(4):527-34.

[28] Vittal V, Shankar V, Kutty K, Kumar SA. An Interventional Study of Physical Activity on HbA1C and VO2max in Type 2 Diabetes Mellitus. Indian journal of physiology and pharmacology. 2016;60(1):76-81.

[29] Ahmad AM. Moderate-intensity continuous training: is it as good as high-intensity interval training for glycemic control in type 2 diabetes? Journal of exercise rehabilitation. 2019;15(2):327.

[30] Silva LRB, Gentil P, Seguro CS, de Oliveira JCM, Silva MS, Marques VA, et al. High-Intensity Interval Training Improves Cardiac Autonomic Function in Patients with Type 2 Diabetes: A Randomized Controlled Trial. Biology. 2022;11(1):66.

[31] Francois ME, Little JP. Effectiveness and safety of high-intensity interval training in patients with type 2 diabetes. Diabetes Spectrum. 2015;28(1):39-44.

[32] Delfan M, Delphan M, Kordi MR, Ravasi AA, Safa M, Gorgani-Firuzjaee S, et al. High intensity interval training improves diabetic cardiomyopathy via miR-1 dependent suppression of cardiomyocyte apoptosis in diabetic rats. Journal of Diabetes & Metabolic Disorders. 2020;19(1):145-52.

[33] Liu J-x, Zhu L, Li P-j, Li N, Xu Y-b. Effectiveness of high-intensity interval training on glycemic control and cardiorespiratory fitness in patients with type 2 diabetes: a systematic review and meta-analysis. Aging clinical and experimental research. 2019;31(5):575-93.

[34] Kaur J. A comprehensive review on metabolic syndrome. Cardiology research and practice. 2014;2014.

[35] Sivitz WI. Lipotoxicity and glucotoxicity in type 2 diabetes: effects on development and progression. Postgraduate medicine. 2001;109(4):55-64.

[36] Adela R, Banerjee SK. GDF-15 as a target and biomarker for diabetes and cardiovascular diseases: a translational prospective. Journal of diabetes research. 2015;2015.

[37] Macia L, Tsai VW-W, Nguyen AD, Johnen H, Kuffner T, Shi Y-C, et al. Macrophage inhibitory cytokine 1 (MIC-1/GDF15) decreases food intake, body weight and improves glucose tolerance in mice on normal & obesogenic diets. PloS one. 2012;7(4):e34868.

[38] Golpasandi, H., Mirzaei, B., & Golpasandi, S. (2019). Glucose, Insulin and Growth/Differentiation Factor-15 Serums Responses to the Acute Effects of Two Intermittent and Continuous Exercises in Sedentary Obese Males. Journal of Inflammatory Diseases, 23(4), 286-295.‏

[39] Van Huyen JPD, Cheval L, Bloch-Faure M, Belair MF, Heudes D, Bruneval P, et al. GDF15 triggers homeostatic proliferation of acid-secreting collecting duct cells. Journal of the American Society of Nephrology. 2008;19(10):1965-74.

[40] Ebadi, N., Zolfaghari, M. R., & Ghaderi Pakdel, F. (2021). The effect of aerobic and interval training with the astaxanthin supplementation on cardiac biomarkers and insulin resistance in type 2 diabetic rats. Daneshvar Medicine, 28(5), 23-36.‏

[41] Galliera E, Lombardi G, Marazzi MG, Grasso D, Vianello E, Pozzoni R, et al. Acute exercise in elite rugby players increases the circulating level of the cardiovascular biomarker GDF-15. Scandinavian Journal of Clinical and Laboratory Investigation. 2014;74(6):492-9.

[42] Munk PS, Valborgland T, Butt N, Larsen AI. Response of growth differentiation factor-15 to percutaneous coronary intervention and regular exercise training. Scandinavian Cardiovascular Journal. 2011;45(1):27-32.

[43] Samarghandian S, Azimi-Nezhad M, Farkhondeh T. Crocin attenuate Tumor Necrosis Factor-alpha (TNF-α) and interleukin-6 (IL-6) in streptozotocin-induced diabetic rat aorta. Cytokine. 2016;88:20-8.

[44] Boskabady MH, Farkhondeh T. Antiinflammatory, antioxidant, and immunomodulatory effects of Crocus sativus L. and its main constituents. Phytotherapy Research. 2016;30(7):1072-94.

[45] Karstoft K, Pedersen BK. Exercise and type 2 diabetes: focus on metabolism and inflammation. Immunology and cell biology. 2016;94(2):146-50.

[46] Støa EM, Meling S, Nyhus L-K, Strømstad G, Mangerud KM, Helgerud J, et al. High-intensity aerobic interval training improves aerobic fitness and HbA1c among persons diagnosed with type 2 diabetes. European journal of applied physiology. 2017;117(3):455-67.

[47] Karstoft K, Winding K, Knudsen SH, Nielsen JS, Thomsen C, Pedersen BK, et al. The effects of free-living interval-walking training on glycemic control, body composition, and physical fitness in type 2 diabetic patients: a randomized, controlled trial. Diabetes care. 2013;36(2):228-36.

[48] Mitranun W, Deerochanawong C, Tanaka H, Suksom D. Continuous vs interval training on glycemic control and macro‐and microvascular reactivity in type 2 diabetic patients. Scandinavian journal of medicine & science in sports. 2014;24(2):e69-e76.